Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies Philip E. LeeMary C. TierneyPaula A. Rochon Review 18 July 2016 Pages: 407 - 420
Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status Martinus A. BeekPaul D. GobardhanErnest J. T. Luiten Review 21 July 2016 Pages: 421 - 432
Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants Saeam ShinIn Sik HwangJong Rak Choi Preclinical study 06 July 2016 Pages: 433 - 440
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion Abhijit MazumdarGraham M. PoagePowel H. Brown Preclinical study Open access 08 July 2016 Pages: 441 - 454
Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer Juan ZhangJie SunYuntao Xie Preclinical study 08 July 2016 Pages: 455 - 462
Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families Taru A. MuranenNasim MavaddatHeli Nevanlinna Preclinical study Open access 20 July 2016 Pages: 463 - 469
Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography Roy J. P. WeberRob M. G. van BommelLucien E. M. Duijm Clinical trial 08 July 2016 Pages: 471 - 483
SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer Z. A. NahlehW. E. BarlowG. N. Hortobagyi Clinical trial Open access 08 July 2016 Pages: 485 - 495
Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial Scott C. AdamsRoanne J. SegalKerry S. Courneya Clinical trial 09 July 2016 Pages: 497 - 507
Effect of a multidiscipline mentor-based program, Be Resilient to Breast Cancer (BRBC), on female breast cancer survivors in mainland China—A randomized, controlled, theoretically-derived intervention trial Zeng Jie YeMu Zi LiangXiao Ming Quan Clinical trial 11 July 2016 Pages: 509 - 522
The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis Tracy A. BattagliaJulie S. DarnellElizabeth Calhoun Clinical trial 18 July 2016 Pages: 523 - 534
Ultrasound-guided breast-conserving surgery for early-stage palpable and nonpalpable invasive breast cancer: decreased excision volume at unchanged tumor-free resection margin W. A. SlijkhuisE. M. NoordaJ. W. C. Gratama Clinical trial 21 July 2016 Pages: 535 - 541
Patterns and determinants of receipt of follow-up mammography and/or clinical examination in a cohort of Italian breast cancer survivors Orietta GiulianiSilvia ManciniFabio Falcini Epidemiology 08 July 2016 Pages: 543 - 551
A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women Giorgio SecretoSabina SieriVittorio Krogh Epidemiology 09 July 2016 Pages: 553 - 561
Predictors of enduring clinical distress in women with breast cancer Deborah N. N. Lo-Fo-WongHanneke C. J. M. de HaesMirjam A. G. Sprangers Epidemiology Open access 14 July 2016 Pages: 563 - 572
Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries Michael T. HalpernDeborah Schrag Epidemiology 15 July 2016 Pages: 573 - 581
Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study Anand K. NarayanKala VisvanathanSusan C. Harvey Epidemiology 21 July 2016 Pages: 583 - 589
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials Adam R. BrentnallJack CuzickMitchell Dowsett Brief Report 11 July 2016 Pages: 591 - 596
Perioperative biology in primary breast cancer: selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach Juan GaronaDaniel F. Alonso Letter to the Editor 08 July 2016 Pages: 597 - 599
Mastectomy versus breast conservation treatment: is there a true survival difference? Mona P. Tan Letter to the Editor 11 July 2016 Pages: 601 - 603
Retraction Note to: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways Aamir AhmadZhiwei WangFazlul H. Sarkar Retraction Note 13 July 2016 Pages: 605 - 605
Retraction Note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors Aamir AhmadZhiwei WangFazlul H. Sarkar Retraction Note 13 July 2016 Pages: 607 - 607
